Related Experiment Video
Updated: Jul 3, 2026

Development of an In Vitro Ocular Platform to Test Contact Lenses
Published on: April 6, 2016
Corneal permeation studies of everolimus microemulsion
Yuecel Baspinar1, Eckart Bertelmann, Uwe Pleyer
1Institute of Pharmacy, Free University of Berlin, Berlin, Germany. baspinar@zedat.fu-berlin.de
Purpose:
To prevent corneal-graft rejection, the topical application of an immunosuppressive drug is an alternative to the systemic application of immunosuppressive drugs or corticosteroids, which may have adverse side effects. The aim of this study was to determine the permeation rate of everolimus through freshly isolated pig cornea (ex vivo).
Methods:
A fluorescence polarization immunoassay with a commercially available assay system was used to quantify everolimus in the acceptor samples of the permeation tests.
Results:
Everolimus is a poorly soluble drug and was, therefore, incorporated in an eye-administrable microemulsion. The stability of this microemulsion containing 0.1% (1 mg/mL) of the drug was satisfying over a period of 12 months. A concentration of 8.64 ng/mL was already reached 30 min after administration of the microemulsion to the cornea.
Conclusions:
This everolimus-containing microemulsion is a promising ocular formulation for preventing corneal-graft rejection.
Related Concept Videos
Ophthalmic Drug Delivery Systems
Bioavailability Enhancement: Drug Permeability Enhancement
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...

